Back to Results
First PageMeta Content
Biology / Transthyretin / Health / Medicine


Phase I First-in-Human Trial of ALN-TTRsc, A Novel RNA Interference Therapeutic for the Treatment of Familial Amyloidotic Cardiomyopathy (FAC) Tracy Zimmermann,1 Verena Karsten,1 Jamie Harrop,1 Amy Chan,1 Joseph Chiesa,2
Add to Reading List

Open Document

File Size: 784,91 KB

Share Result on Facebook
UPDATE